InsidersTradesSigma
Follow the Aptargroup INC stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Chemicals & Materials sector, Aptargroup INC has recorded 36 public disclosures. Market capitalisation: €8.5bn. The latest transaction was reported on 8 November 2021 (Retenue fiscale). Among the most active insiders: Kampouri Monnas Giovanna. All data is accessible without an account.
36
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€180,984
5 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Aptargroup INC Strong Buy (bullish), based on 7 analysts. Average price target: US$165.43.
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,180 of 29,062 companies
59.0
score / 100
Value56
Quality62
FCF yld3.4%
Earn yld4.6%
EV/EBITDA12.2x
ROE13%
Gross mgn37%
Net mgn10%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 November 2021
Declarations36 total
1,431 shares@ US$131.500.0022% mcap23.7% of flowCommon StockSEC:0001757051-21-000006:0
379 shares@ US$131.500.0006% mcap50.0% of flowCommon StockSEC:0001758130-21-000004:0
2,439 shares@ US$138.72100.0% of flowCommon StockSEC:0001795130-21-000003:0
126 shares@ US$136.76100.0% of flowCommon StockSEC:0001817362-21-000002:0
42,735 shares@ US$71.12100.0% of flowCommon StockSEC:0001662085-21-000004:0
1,029 shares0Common StockSEC:0001664944-21-000005:0
983 shares0Common StockSEC:0000896622-21-000045:0
983 shares0Common StockSEC:0000896622-21-000047:0
983 shares0Common StockSEC:0001140361-21-018735:0
983 shares0Common StockSEC:0001140361-21-018728:0
983 shares0Common StockSEC:0001140361-21-018732:0
983 shares0Common StockSEC:0001140361-21-018730:0
1,114 shares0Common StockSEC:0000896622-21-000043:0
983 shares0Common StockSEC:0001140361-21-018739:0
2,000 shares@ US$64.60100.0% of flowCommon StockSEC:0001744506-21-000004:0
1,393 shares@ US$157.7452.6% of flowCommon StockSEC:0001757051-21-000004:0
917 shares0Common StockSEC:0001140361-21-016413:0
917 shares0Common StockSEC:0000896622-21-000037:0
917 shares0Common StockSEC:0001140361-21-016417:0
917 shares0Common StockSEC:0001140361-21-016423:0
917 shares0Common StockSEC:0001140361-21-016415:0
917 shares0Common StockSEC:0001140361-21-016410:0
917 shares0Common StockSEC:0000896622-21-000031:0
25 of 36 declarations
关于 Aptargroup INC
AptarGroup Inc. (NYSE: ATR) 是一家总部位于美国伊利诺伊州水晶湖的美国工业公司。公司成立于1992年，其前身可追溯到更早的金属加工和分配技术业务，Aptar已在包装和药物输送应用领域的计量、分配和保护技术方面建立了全球特许经营权。该公司在大约20个国家拥有约14,000名员工，这突显了其广泛的国际制造和商业足迹，为医疗保健、美容和消费品领域的客户提供支持。([aptar.com](https://aptar.com/en-us/about-aptar?utm_source=openai)) Aptar通过三个主要部门运营：制药、美容和封盖。制药是公司最具战略重要性的引擎，涵盖鼻喷雾系统、吸入组件、口服给药解决方案、注射组件以及相关的药物开发服务。美容部门通过泵、阀门、气雾剂执行器和无气分配系统服务于香水、护肤、彩妆和个人护理市场。封盖部门为食品、饮料、家庭护理和其他消费应用提供分配和封盖解决方案。这种组合使Aptar在医疗保健和消费终端市场都获得了均衡的敞口，同时支持了相对有弹性的收入基础。([stockanalysis.com](https://stockanalysis.com/stocks/atr/company/?utm_source=openai)) 从竞争角度来看，Aptar将自己定位为技术主导的供应商，而非商品化的包装制造商。其护城河建立在专有工程、材料科学、监管专业知识以及与全球品牌所有者和制药公司的深度合作之上。在制药领域，Aptar在鼻腔和肺部给药平台方面建立了强大的信誉，这些平台对精度、患者可用性和法规遵从性至关重要。在美容和消费品分配领域，公司受益于与主要品牌的长期合作关系以及对高端、差异化包装形式的需求。([aptar.com](https://aptar.com/en-us/about-aptar?utm_source=openai)) 近期发展表明公司持续创新和审慎的资本配置。2025年，Aptar宣布对其SmartTrack™体外-硅内平台进行临床验证研究，该平台旨在帮助加速某些加压计量吸入器的FDA批准途径。公司还发布了其2024年可持续发展报告，强调了环境和循环经济举措。最近，Aptar完成了有针对性的收购，以加强其制药能力并支持口服给药和临床试验材料制造。其2025年全年业绩显示盈利增长，并包括一项新的600 million美元股票回购授权，这对关注股东回报的投资者来说值得关注。总体而言，Aptar是一家优质的工业复合型公司，拥有全球业务、在药物输送领域具有防御性的利基市场，并且其股票在美国纽约证券交易所上市。([investors.aptar.com](https://investors.aptar.com/news/news-details/2025/Aptar-Announces-Clinical-Validation-Study-to-Accelerate-US-FDA-Approval-of-SmartTrack-In-Vitro-in-Silico-Platform-for-Pressurized-Metered-Dose-Inhalers/default.aspx?utm_source=openai))
